Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

RARX - Ra Pharmaceuticals Inc.

Previous close
47.995
0   0%

Share volume: 0
Last Updated: Wed 01 Apr 2020 06:00:00 AM CEST
Pharmaceuticals: Major: -0.03%

PREVIOUS CLOSE
CHG
CHG%
$48.00
0.00
0.00%
This ticker is disabled and data are no longer maintained and up to date.
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
45%
Profitability 50%
Dept financing 11%
Liquidity 75%
Performance 40%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
0   0%
1 Month
0   0%
3 Months
0   0%
6 Months
0   0%
1 Year
0   0%
2 Year
0   0%
Key data
Stock price
$48.00
P/E Ratio 
N/A
DAY RANGE
$48.00 - $48.00
EPS 
-$2.29
52 WEEK RANGE
$19.64 - $48.02
52 WEEK CHANGE
$130.88
MARKET CAP 
2.262 B
YIELD 
N/A
SHARES OUTSTANDING 
47.143 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
0.00
PUBLIC FLOAT 
$45,955,704
AVERAGE 10 VOLUME 
$2,378,753
AVERAGE 30 VOLUME 
$1,446,350
Company detail
CEO: Douglas A. Treco
Region: US
Website: http://www.rapharma.com
Employees: 89
IPO year: -
Issue type: Common Stock
Market: NASDAQ
Industry: Pharmaceuticals: Major
Sector: Health Technology

Ra Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery and development of peptide-based drugs. It uses Extreme Diversity platform that allows to produce synthetic macrocyclic peptides. The company was founded by James W. Broderick and Douglas A. Treco on June 27, 2008 and is headquartered in Cambridge, MA.

Recent news